Glutathione inhibits tyrosinase, the enzyme responsible for melanin production
Before Datroway was approved, it went through multiple phases of clinical trials to assess how well it worked, what side effects it caused, and whether it was better than existing treatments
CJC-1295 with DAC has a half-life of approximately 68 days, meaning twice-weekly injections (typically Monday and Thursday) maintain stable plasma levels
Adverse events associated with intravenous glutathione therapy. Referenced in: PMC11862975
Warning signs include itching, rash, swelling, or difficulty breathing
Returns & Exchanges: You must contact us within 14 days of receiving your order by emailing [email protected] and requesting an RMA (Return Merchandise Authorization) Number